Publications by authors named "Dirk F Hendriks"

Claim this Profile
C
Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients.
Raf Brouns, Evelien Heylen, Rishi Sheorajpanday, Johan L Willemse, Jan Kunnen, Dirk F Hendriks

Clin Neurol Neurosurg· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major carboxypeptidase N deficiency.
Johan L Willemse, David Chen, Dirk F Hendriks

Clin Chim Acta· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: development of highly selective CPU substrates as useful tools for assay development.
Johan L Willemse, Magnus Polla, Thomas Olsson, Dirk F Hendriks

Clin Chim Acta· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over.
Kathleen Deiteren, Georgiana Surpateanu, Kambiz Gilany, Johan L Willemse, Dirk F Hendriks

Biochim Biophys Acta· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for procarboxypepidase U (TAFI) in thrombosis.
Johan L Willemse, Dirk F Hendriks

Front Biosci· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation.
Johan L Willemse, Dirk F Hendriks

Clin Chim Acta· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays.
Johan L Willemse, Magnus Polla, Dirk F Hendriks

Anal Biochem· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge.
Johan L Willemse, Dirk F Hendriks

Clin Chem· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different effects of low-dose transdermal and oral oestrogen therapy on procarboxy-peptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled study.
Marinka S Post, Judith R Leurs, Marius J van der Mooren, W Marchien van Baal, Dirk F Hendriks

Thromb Haemost· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women.
Tatjana E Vogelvang, Judith R Leurs, Marius J van der Mooren, Velja Mijatovic, Dirk F Hendriks

Menopause· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis